Anuh Pharma Ltd.

BSE: ANUHPHR506260ISIN INE489G01022

Healthcare
Pharmaceuticals
BSE Healthcare

Share price

₹82.89+2.02 (+2.50%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

Splits and bonuses

15 Jul 2025 · Bonus 1:1

52W high: ₹99.50
52W low: ₹66.72
Off 52W high: -16.69%
1M return: -1.44%
3M return: +4.69%
6M return: +0.18%
1Y return: -5.46%
20D avg volume: 12,020
50 DMA: ₹85.31
200 DMA: ₹79.79

Key ratios Standalone

Market cap: ₹830.76 Cr
Current price: ₹82.89
52W high / low: ₹99.50 / ₹66.72
Face value: ₹5.00
P/E: 17.38
P/B: 2.74
EPS (TTM): ₹4.77
Book value / share: ₹30.25
ROE: 15.76%
ROCE: 15.40%
Operating margin: 9.48%
Net margin: 6.05%
Debt / equity: 0.00
Net debt: ₹-8.06 Cr
Interest cover: 116.36
Dividend yield: 1.81%
Dividend / share (TTM): ₹1.50
Payout: 31.45%
Cash conversion cycle: 94.0 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	185.24	193.81	202.12	197.18	185.88	186.48	198.14	159.51	165.95	137.91	163.89	172.10
	0.61	3.08	-1.25	4.11	0.98	3.39	1.40	0.94	3.40	3.72	2.82	3.66
	185.85	196.89	200.86	201.29	186.86	189.87	199.54	160.45	169.35	141.63	166.71	175.76
	170.80	179.96	185.34	183.46	176.94	178.91	182.26	147.19	151.16	129.36	147.00	150.45
	141.83	159.96	140.71	114.31	131.51	123.91	137.92	118.65	114.93	91.78	117.36	117.26
	0.48	4.14	2.83	31.48	18.39	26.50	10.93	14.55	6.71	6.36	7.66	0.89
	7.46	7.35	6.35	6.91	6.75	6.30	6.85	5.54	5.52	5.14	4.94	5.04
	0.05	0.00	0.11	0.08	0.08	0.21	0.03	0.28	0.16	0.14	0.10	0.14
	2.45	2.43	3.00	3.00	2.86	2.52	2.76	2.18	1.92	1.88	2.23	2.20
	23.07	21.86	24.66	22.19	22.72	17.27	24.16	18.71	18.32	17.00	19.08	17.28
	15.05	16.93	15.52	17.83	9.92	10.95	17.28	13.27	18.19	12.27	19.72	25.31
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	15.05	16.93	15.52	17.83	9.92	10.95	17.28	13.27	18.19	12.27	19.72	25.31
	3.83	5.50	3.84	4.38	2.31	2.65	4.82	2.92	3.15	2.76	4.36	6.19
	11.21	11.43	11.68	13.45	7.61	8.30	12.46	10.34	15.04	9.51	15.36	19.11
	1.12	1.14	1.17	1.34	0.76	1.66	2.49	2.06	3.00	1.90	3.06	3.81
Key metrics
	17.55	19.36	18.63	20.91	12.86	13.68	20.07	15.73	20.27	14.29	22.05	27.65
	9.50%	10.00%	9.20%	10.60%	6.90%	7.30%	10.10%	9.90%	12.20%	10.40%	13.50%	16.10%
	6.10%	5.90%	5.80%	6.80%	4.10%	4.50%	6.30%	6.50%	9.10%	6.90%	9.40%	11.10%
	4.20%	—	4.40%	—	3.00%	—	5.30%	—	—	—	—	—
	-0.30%	3.90%	2.00%	23.60%	12.00%	35.20%	20.90%	-7.30%	—	—	—	—
	47.30%	37.70%	-6.30%	30.10%	-49.40%	-12.70%	-18.90%	-45.90%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	778.35	771.66	661.51	647.00	527.49	486.65
	6.55	4.36	9.46	12.10	6.12	5.20
	784.89	776.01	670.97	659.10	533.60	491.84
	719.56	721.79	609.97	580.79	486.13	452.72
	556.81	510.44	463.28	489.73	377.01	351.71
	38.93	79.20	38.55	12.18	10.99	30.83
	28.07	26.30	23.04	19.39	17.15	15.10
	0.24	0.47	0.62	0.35	0.22	0.96
	10.88	11.38	8.74	8.58	9.70	11.96
	91.78	83.97	78.20	65.80	57.58	47.02
	65.33	54.22	61.01	78.31	47.47	39.12
	0.00	0.00	0.00	—	—	—
	65.33	54.22	61.01	78.31	47.47	39.12
	17.55	13.18	13.65	18.25	11.29	8.56
	47.77	41.05	47.35	60.06	36.18	30.56
	4.77	4.10	9.45	11.98	7.22	6.10
Key metrics
	76.45	66.07	70.37	87.24	57.39	52.04
	9.82%	8.60%	10.60%	13.50%	10.90%	10.70%
	6.14%	5.30%	7.20%	9.30%	6.90%	6.30%
	—	15.40%	18.80%	—	—	—
	6.62%	16.70%	2.20%	22.70%	8.40%	—
	23.40%	-13.30%	-21.20%	66.00%	18.40%	—
	—	-10.88	17.16	—	—	—
	—	-0.07	0.78	—	—	—
	—	0.00	0.03	—	—	—
	—	-8.06	-9.06	—	—	—
	—	94.0	73.7	—	—	—
Balance sheet
	—	557.37	506.63	—	—	—
	—	451.32	376.17	—	—	—
	—	8.06	19.56	—	—	—
	—	238.63	215.87	—	—	—
	—	147.75	74.48	—	—	—
	—	10.00	11.39	—	—	—
	—	47.99	49.58	—	—	—
	—	187.66	156.84	—	—	—
	—	203.00	178.51	—	—	—
	—	0.00	10.50	—	—	—
	—	0.00	10.50	—	—	—
	—	0.00	0.00	—	—	—
	—	352.22	326.02	—	—	—
Cash flow
	—	-3.01	37.12	—	—	—
	—	17.84	-19.91	—	—	—
	—	-26.33	-4.86	—	—	—
	—	7.87	19.96	—	—	—

Compounded growth

Sales CAGR 3Y: +13.52%
Sales CAGR 5Y: —
Profit CAGR 3Y: +4.30%
Profit CAGR 5Y: —
Sales YoY (TTM): +6.62%
Profit YoY (TTM): +23.40%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 71.81%

Quarter	September 2026	June 2026
Promoter %	71.81%	71.81%

Holder	Type	Holding	Previous	Change
BHARTI BIPIN SHAH	Promoter	19.43%	19.43%	0.00%
BIPIN NEMCHAND SHAH	Promoter Group	14.69%	14.69%	0.00%
PRAFULLA LALIT SHAH	Promoter Group	14.47%	14.47%	0.00%
BHARAT NEMCHAND SHAH	Promoter	3.73%	3.73%	0.00%
GAURAV SATISH SHAH	Promoter Group	3.19%	3.19%	0.00%
VIVEK BIPIN SHAH	Promoter Group	2.33%	2.33%	0.00%
MRUDULA JAYANTILAL SHAH	Promoter	2.33%	2.33%	0.00%
RITESH BIPIN SHAH	Promoter Group	2.31%	2.31%	0.00%
DINA SATISH SHAH	Promoter	2.22%	2.22%	0.00%
SAMIR JAYANTILAL SHAH	Promoter Group	1.72%	1.72%	0.00%
MICHAEL DSOUZA	Public	1.20%	1.10%	+0.10%
KINJAL SIDDHARTH JHAVERI	Promoter Group	0.81%	0.81%	0.00%
JASMINE SAMIR SHAH	Promoter Group	0.66%	0.66%	0.00%
NEETA KETAN SHAH	Promoter Group	0.52%	0.52%	0.00%
HARSHIT BHARAT SHAH	Promoter Group	0.50%	0.50%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Anuh Pharma Ltd. S	831	82.89	17.38	15.40%	+6.62% TTM	+23.40% TTM	-5.46%

Filings & corporate actions

Recent announcements

Newspaper Publication of the Unaudited Financial Results for the Quarter and half year ended 30th September, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep ....1 Nov 2026 · Company Update / Newspaper Publication
Request received for withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group" to "Public Category".30 Oct 2026 · Company Update / General
Unaudited Financial Results for the Quarter and half year ended 30th September, 2026.30 Oct 2026 · Result / Financial Results
To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter and half year ended 30th September, 2026 and Request received for withdrawal ....30 Oct 2026 · Board Meeting / Outcome of Board Meeting
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Unaudited Financial Results for ....26 Oct 2026 · Board Meeting / Board Meeting
Intimation for receiving the possession of manufacturing facility21 Oct 2026 · Company Update / General
Disclosure of Events under Regulation 30 of SEBI LODR Regulation, 2015 for signing of Asset Transfer Agreement16 Oct 2026 · Company Update / Memorandum of Understanding /Agreements
To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion13 Oct 2026 · Company Update / General
To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion13 Oct 2026 · Others / Outcome without intimation
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants ) Regulation, 2018 for the quarter ended 30th September, 2026 received from Bigshare Services ....12 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation regarding the closure of Trading Window for dealing in Securities of the Company shall remain closed from Thursday, 01st October, 2026 till the expiry of 48 hours after the declaration ....28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Disclosure under Regulation 30 of the SEBI LODR regarding receipt of Demand Order under Section 156 of the Income Tax Act, 1961.18 Sep 2026 · Company Update / General
Investor Presentation for Q1 FY 2026-2719 Aug 2026 · Company Update / Investor Presentation
Disclosure under Regulation 30 of SEBI (LODR), 2015 regarding Change in Management.14 Aug 2026 · Company Update / Change in Management
Disclosure of Announcement under Regulation 30 of SEBI (LODR), 201514 Aug 2026 · Company Update / General
Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company14 Aug 2026 · AGM/EGM / AGM
Outcome of the 66th Annual General Meeting of Anuh Pharma Limited held on Wednesday, 12th August, 202612 Aug 2026 · AGM/EGM / AGM
Newspaper Publication of the Unaudited financial results for the Quarter ended 30th June, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language ....9 Aug 2026 · Company Update / Newspaper Publication
Adoption of Revised Policy of Related Party Transactions.7 Aug 2026 · Company Update / General
Request received for Withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group'' to ''Public Category''.7 Aug 2026 · Company Update / General
Unaudited Financial Results for the Quarter ended 30th June, 2026.7 Aug 2026 · Result / Financial Results
To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter ended 30th June, 2026, Request received for withdrawal of application for reclassification ....7 Aug 2026 · Board Meeting / Outcome of Board Meeting
Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited Financial Results for ....3 Aug 2026 · Board Meeting / Board Meeting
This is to inform to the stock exchange regarding dispatch of physical communication to shareholders who have not registered their email address.18 Jul 2026 · Company Update / General
Pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 that a meeting of the Shareholders of the Company will be held on Wednesday, 12th August, ....18 Jul 2026 · Company Update / Newspaper Publication
Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015 please find enclosed herewith the copy of the Annual Report ....18 Jul 2026 · Others / Reg. 34 (1) Annual Report
In terms of the provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached herewith Notice of the 66th Annual General Meeting of the ....18 Jul 2026 · AGM/EGM / AGM
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026 received from Bigshare Services Private ....14 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation regarding the closure of Trading Window for dealing in Securities of the Company shall remain closed from Wednesday, 01st July, 2026 till the expiry of 48 hours after the declaration ....26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Clarification for Newspaper Publication made on 19th June, 202620 Jun 2026 · Company Update / General
Disclosure under Regulation 30 of the SEBI LODR regarding receipt of Demand Order under Section 156 and Penalty Order under Section 270 of the Income Tax Act, 1961.19 Jun 2026 · Company Update / General
Newspaper Publication for transfer of equity shares of the Company for which Dividend has not been claimed by shareholders for seven consecutive years or more to Investor Education and ....19 Jun 2026 · Company Update / Newspaper Publication
Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2026.29 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Investor Presentation for Q4 FY 2025-2628 May 2026 · Company Update / Investor Presentation
Intimation for filing of the application for reclassification of shareholders from Promoter Group to Public Category25 May 2026 · Company Update / General
Intimation for the Resolution for reclassification of shareholders from Promoter group to Public category22 May 2026 · Company Update / General
Newspaper Publication of the Audited financial results for the Quarter and Year ended 31st March, 2026, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi ....22 May 2026 · Company Update / Newspaper Publication
Adoption for policy for implementation of NFRA circular20 May 2026 · Company Update / General
Appointment of Scrutinizer for the 66th Annual General Meeting.20 May 2026 · Company Update / General
66th Annual General Meeting will be held on Wednesday, 12th August, 2026 through Video Conferencing and other audio visual means.20 May 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 1.5000	5 Aug 2026	5 Aug 2026	—
Final Dividend - Rs. - 1.5000	14 Aug 2025	15 Aug 2025	—
Bonus issue 1:1	15 Jul 2025	15 Jul 2025	—
Final Dividend - Rs. - 2.5000	16 Aug 2024	—	—

Board meetings

30 Oct 2026 Board Meeting - Financial Results
7 Aug 2026 Board Meeting - Financial Results